Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

24 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Imovax Articles

Simcere buys largest stake in Jiansu Yanshen

28 May 2009

Crucell licenses rabies MAbs to Sanofi Pasteur

14 January 2008

Akorn and India's Serum Inst sign US vacc deal

5 November 2007

Swiss Novartis chooses Cambridge, USA, as site for vaccines/diagnostics HQ

22 December 2006

New Bosnia/Herzegovina law "potential disaster"

26 July 2006

Crucell evaluating MAb against rabies

22 November 2004

New typhoid vaccine launched in india

19 May 2003

Vietnam plan to boost vaccines output

20 January 2000

HMR to introduce Amaryl ) in India

31 March 1999

HMR & Chiron In Indian JV

3 June 1998

Chiron's Rabies Vaccine OKed In USA

6 November 1997

Vaccine News From ECCMID

3 April 1995

Quintiles To Set Up East Asia Office In Singapore

13 March 1995

Verorab Launch In China

14 November 1994

ORAL RABIES VACCINE IN WORLD TRIALS

11 July 1994

WORLD PRODUCT NEWS IN BRIEF

24 January 1994

FRENCH BLOOD SCANDAL: MERIEUX EXPORT ROW

9 November 1992

SUCCESS CLAIMED FOR RABIES VACCINE

20 January 1992

Showing 1-18 of 18 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
  • Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
  • AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
  • Boehringer Ingelheim gets FDA warning letter on cGMP failures
  • Italy's pharma market slump set to continue, warns GlobalData
  • US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
  • Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
  • AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
  • Boehringer Ingelheim gets FDA warning letter on cGMP failures
  • Italy's pharma market slump set to continue, warns GlobalData

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS